Nmda nr2b antagonists for the treatment of depression

Details Nmda nr2b antagonists for the treatment of depression Nmda nr2b antagonists for the treatment of depression

A - Human Necessities

61

K

A61K 31/453 (2006.01) A61K 31/451 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2357929

The invention provides new methods for treating certain disorders resulting from neurodegeneration and for treating depression which comprise administration of NR2B subunit selective NMDA antagonists. The disorders that can be treating by the invention include hearing loss, vision loss, neurodegeneration caused by epileptic seizures, neurotoxin poisoning, Restless Leg Syndrome, multi-system atrophy, non-vascular headache, and depression.

Affiliated with

Also associated with

Rating

Nmda nr2b antagonists for the treatment of depression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nmda nr2b antagonists for the treatment of depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nmda nr2b antagonists for the treatment of depression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1658516